Compare FERG & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FERG | GEHC |
|---|---|---|
| Founded | 1887 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Computer Software: Prepackaged Software |
| Sector | Miscellaneous | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.0B | 37.0B |
| IPO Year | 2024 | 2022 |
| Metric | FERG | GEHC |
|---|---|---|
| Price | $256.15 | $82.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 22 |
| Target Price | ★ $290.55 | $87.85 |
| AVG Volume (30 Days) | 1.5M | ★ 4.1M |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.40% | 0.20% |
| EPS Growth | ★ 9.26 | 4.84 |
| EPS | ★ 8.63 | 3.44 |
| Revenue | ★ $30,762,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $8.60 | $6.01 |
| Revenue Next Year | $7.00 | $4.87 |
| P/E Ratio | $29.56 | ★ $23.83 |
| Revenue Growth | 3.80 | ★ 4.84 |
| 52 Week Low | $212.13 | $58.75 |
| 52 Week High | $271.64 | $89.77 |
| Indicator | FERG | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 63.55 | 68.64 |
| Support Level | $217.69 | $60.90 |
| Resistance Level | $268.63 | $86.56 |
| Average True Range (ATR) | 8.44 | 2.37 |
| MACD | 2.02 | 0.22 |
| Stochastic Oscillator | 73.32 | 74.18 |
Ferguson distributes plumbing and HVAC products to North American repair, maintenance, and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 37,000 suppliers. Ferguson engages customers through approximately 1,700 North American branches, over the phone, online, and in residential showrooms. The firm sold its UK business in 2021 and is now solely focused on the North American market.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).